Publisher
Springer Science and Business Media LLC
Subject
Endocrinology,Endocrinology, Diabetes and Metabolism
Reference10 articles.
1. Azziz, R. et al. The polycystic ovary syndrome. Nat. Rev. Dis. Primers 2, 16057 (2016).
2. Abbott, D. H., Dumesic, D. A., Levine, J. E., Dunaif, A. & Padmanabhan, V. in Androgen Excess Disorders in Women 2nd edn Ch. 23 (eds Azziz, R., Nestler, J. E. & Dewailly, D.) 259–272 (Humana Press, 2006).
3. Caldwell, A. S. et al. Neuroendocrine androgen action is a key extraovarian mediator in the development of polycystic ovary syndrome. Proc. Natl Acad. Sci. USA 114, E3334–E3343 (2017).
4. Caldwell, A. S. et al. Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models. Endocrinology 155, 3146–3159 (2014).
5. De Leo, V., Lanzetta, D., D'Antona, D., la Marca, A. & Morgante, G. Hormonal effects of flutamide in young women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 83, 99–102 (1998).
Cited by
16 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献